1.
Thaçi D, Puig L, Motegi S- ichiro, Papp K, Stein Gold L, Kircik L, et al. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials. Acta Derm Venereol [Internet]. 2026 May 21 [cited 2026 May 26];106:adv-2025. Available from: https://medicaljournalssweden.se/actadv/article/view/46159